May 12, 2023 · Updates as of June 16, 2021. Clarified the differences between laboratory-based and point-of-care NAATs. A Nucleic Acid Amplification Test, or NAAT, is a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19. NAATs detect genetic material (nucleic acids). NAATs for SARS-CoV-2 specifically identify the RNA (ribonucleic ...
- Specimen Collection
Collecting and Handling Specimens Safely. For healthcare...
- Point-Of-Care (Poc)
Key Points. This guidance provides information on the...
- CDC Covid-19 Tests
Other Diagnostic Tests for SARS-CoV-2; CDC COVID-19 Tests...
- Other Diagnostic Tests for SARS-CoV-2
Breath Tests. Other diagnostic tests may be used to detect...
- Your Health
Given new evidence on the B.1.617.2 (Delta) variant, CDC has...
- Recommendations for The Laboratory-Based Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae
BOX 1. Summary of recommendations. Nucleic acid...
- Specimen Collection
- Examples of Screening Testing Include
- How to Conduct Screening Testing
- Settings to Prioritize For Screening Testing
Point-in-time screening testingSerial screening testingWhen screening testing is used, it should be applied to participants regardless of vaccination status. Any type of viral testcan be used for screening purposes; however, consider the characteristics (including accessibility, accuracy and efficiency) of different test types to determine which best suits screening testing needs. People without sympto...
Settings that should be prioritized for screening testing include facilities and situations where transmission risk is high and the population served is at high risk of severe outcomes from COVID-19 or there is limited access to healthcare, including: 1. Specific settingsthat have demonstrated high potential for rapid and widespread virus spread to...
The Coronavirus SARS-CoV-2 (COVID-19) by nucleic acid amplification test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for U.S. laboratories certified under CLIA to perform high complexity tests. This test has not been FDA cleared or approved. In compliance with this authorization, please visit https://www ...
Mar 6, 2023 · Everyone who has symptoms that are consistent with COVID-19 and people with known high-risk exposures to SARS-CoV-2 should be tested for SARS-CoV-2 infection. Such testing should employ either a nucleic acid amplification test (NAAT) or an antigen test to detect SARS-CoV-2. Testing may also be used for screening and determining the length of a ...
May 11, 2023 · SARS-CoV-2, NAA: 94500-6: Reflex Table for SARS-CoV-2, NAA; Order Code Order Name Result Code Result Name UofM Result LOINC; Reflex 1: 998900: SARS-CoV-2, NAA 2 DAY ...
May 9, 2023 · Diagnostic Tests. SARS-CoV-2 (COVID-19) by NAA (3002638) ARUP’s NAA test for SARS-CoV-2 is designed to detect SARS-CoV-2 RNA in respiratory specimens. Detailed information about ARUP’s SARS-CoV-2 by NAA test, including methodology, results reporting, and test performance, can be found in the Coronavirus Disease 2019 (COVID-19) Frequently ...
Nov 30, 2021 · Study: Analytical sensitivity and effectiveness of different SARS-CoV-2 testing options. Image Credit: anyaivanova / Shutterstock.com. This news article was a review of a preliminary scientific ...
Yahoo Web Search
About 2,040,000 search results
- SARS-CoV-2
Virus that causes COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the COVID-19 pandemic. The virus previously had a provisional name, 2019 novel coronavirus (2019-nCoV), and has also been called the human coronavirus 2019 (HCoV-19 or hCoV-19). Wikipedia
